Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Dion Groothof; Stephan J.L. Bakker; Nicole S. Erler

doi:10.1056/NEJMc2401126

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Dion Groothof^*
, Stephan J.L. Bakker
, Nicole S. Erler

^*Corresponding author for this work

Epidemiology

University Medical Centre Groningen

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

8 Downloads (Pure)

Original language	English
Pages (from-to)	1153-1154
Number of pages	2
Journal	The New England journal of medicine
Volume	390
Issue number	12
DOIs	https://doi.org/10.1056/NEJMc2401126
Publication status	Published - 20 Mar 2024

Access to Document

10.1056/NEJMc2401126

Sparsentan versus Irbesartan in Focal Segmental GlomerulosclerosisFinal published version, 314 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{d6aabd2111744c8b8d61f28834788e78,

title = "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis",

author = "Dion Groothof and Bakker, \{Stephan J.L.\} and Erler, \{Nicole S.\}",

year = "2024",

month = mar,

day = "20",

doi = "10.1056/NEJMc2401126",

language = "English",

volume = "390",

pages = "1153--1154",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "12",

}

TY - JOUR

T1 - Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

AU - Groothof, Dion

AU - Bakker, Stephan J.L.

AU - Erler, Nicole S.

PY - 2024/3/20

Y1 - 2024/3/20

UR - https://www.scopus.com/pages/publications/85188494521

U2 - 10.1056/NEJMc2401126

DO - 10.1056/NEJMc2401126

M3 - Comment/Letter to the editor

C2 - 38507767

AN - SCOPUS:85188494521

SN - 0028-4793

VL - 390

SP - 1153

EP - 1154

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 12

ER -

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Access to Document

Other files and links

Cite this